mapracorat inn code names antiinflammatory drug belonging experimental class selective glucocorticoid receptor agonists segras clinical trials topical treatment atopic inflammation following cataract allergic preliminary investigation treatment keratoconjunctivitis sicca conducted cellular phase ii clinical trials mapracorat started summer one trial double blind dose finding study ointment atopic dermatitis tested concentrations versus placebo four weeks around patients trial conducted intendis part bayer healthcare pharmaceuticals specialized dermatology completed september october trial also double blind design evaluated ophthalmic suspension treatment inflammation following cataract surgery various concentrations dosing schemes tested versus placebo patients study conducted bausch lomb completed september successor study phase iii trial started november completed august january study results available drug article relating musculoskeletal system stub help wikipedia expanding antineoplastic immunomodulatory drug article stub help wikipedia expanding dermatologic drug article stub help wikipedia expanding httpsenwikipediaorgwikimapracorat